Removing cancer cell debris improves conventional cancer treatments

(Brigham and Women's Hospital) Cancer therapies are designed to kill tumor cells, but produce tumor cell debris in the process. In a study published in The Journal of Experimental Medicine, researchers from Brigham and Women's Hospital and colleagues show that leftover debris can stimulate inflammation and tumor growth, but that molecules called resolvins can block that unwanted inflammatory response. The findings point towards a new way to enhance the effectiveness of current cancer therapies and potentially prevent tumor recurrence.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news